Clinical pharmacologic study of 1-acetyl-2-picolinoyl hydrazine (NSC-68626).
D000818:Animals; D002279:Carcinoma 256, Walker / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D006801:Humans; D006834:Hydrazines / Q000008:administration & dosage / Q000627:therapeutic use*; D051381:Rats
D006834:Hydrazines